We Provide Tailored Sourcing Solutions for Generic Pharma
Our Story
Lantaris was founded with a mission: to streamline API sourcing for generic product development and manufacturing. With over 25 years of expertise in strategic API sourcing, supplier relationship management, supply risk management, and complex project management, our team is your partner in optimizing your supply chain.
Our Expertise
Our founder and team have held pivotal roles in esteemed generic multinationals, including Actavis, Sandoz, Viatris, Teva, and Alvogen. This experience equips us with unmatched insights into the challenges and opportunities inherent in API sourcing.
Our Global Reach
Our sourcing associates are strategically located in major API manufacturing hubs, such as:
- China
- India
- Taiwan
- South Korea
- Europe
- Latin America
This extensive global network provides us with valuable local market intelligence, enabling us to identify the best API solutions tailored to each client’s needs.
Our Approach
At Lantaris, we prioritize building direct relationships between our clients and API manufacturers. Unlike traditional sourcing companies, we don’t buy and sell APIs. Instead, we specialize in identifying optimal suppliers, negotiating on your behalf, and facilitating direct purchasing relationships.
Our Commitment
We are committed to helping generic product manufacturers optimize their API sourcing, reduce costs and supply risks, and accelerate time-to-market.
The Gap We Fill
Many small and medium-sized generic pharmaceutical companies lack dedicated, in-house sourcing teams and often rely on non-specialized functions such as Operational Procurement, R&D, or even Business Development to manage their API sourcing.
These non-specialized teams often lack the expertise needed for thorough supplier due diligence and effective negotiation. Without access to comprehensive market intelligence—beyond standard databases or internet searches—companies frequently turn to traders, agents, or distributors. This approach can limit supply options, increase costs by up to 25–40%, and compromise product competitiveness. According to industry data, poor sourcing practices can delay product launches by up to 6–12 months, significantly impacting market entry and revenue.
In short, non-specialized teams struggle to ensure a rigorous source selection process, leading to both immediate and long-term risks. For example, inadequate initial selections often force companies to change API sources during critical regulatory reviews or just before launch. This can result in urgent, high-cost decisions that prioritize immediate availability over supplier reliability and quality. One study found that rushed API substitutions can increase costs by up to 30% and jeopardize regulatory compliance.
This is where we make the difference.
At Lantaris, we bring over 25 years of expertise in API sourcing, a global network of trusted contacts, and local presence in key manufacturing regions like China, India, and the EU. Our support ensures you select the right supplier from the beginning, helping you launch on time and stay within budget. This strategic approach can lead to cost savings of 20–40% and a streamlined supply chain that supports profitability throughout the product lifecycle.
Want to experience our sourcing services?
Choose a molecule and contact us today. We’ll conduct a thorough screening and deliver a comprehensive sourcing report—free of charge and with no obligation. Join the many clients who trust us to optimize their API sourcing, mitigate risks, and secure long-term success.
